Commentary on This Article from Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic Study
Year: 2023
Type: editorial
Abstract: Commentary on This Article from Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic Study
Authors: Nabil F. Saba, Selwyn J. Hurwitz, Scott A. Kono, Chung S. Yang, Yang Zhao, Zhengjia Chen, Gabe Sica, Susan Müller, Rachel Moreno-Williams, Melinda Lewis, William Grist, Amy Y. Chen, Charles E. Moore, Taofeek K. Owonikoko, Suresh Ramalingam, Jonathan J. Beitler, Sreenivas Nannapaneni, Hyung Ju C. Shin, Jennifer R. Grandis, Fadlo R. Khuri, Zhuo Georgia Chen, Dong M. Shin
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362625070